226 related articles for article (PubMed ID: 7541833)
21. Mutations in novel peroxin gene PEX26 that cause peroxisome-biogenesis disorders of complementation group 8 provide a genotype-phenotype correlation.
Matsumoto N; Tamura S; Furuki S; Miyata N; Moser A; Shimozawa N; Moser HW; Suzuki Y; Kondo N; Fujiki Y
Am J Hum Genet; 2003 Aug; 73(2):233-46. PubMed ID: 12851857
[TBL] [Abstract][Full Text] [Related]
22. Clinical and Biochemical Pitfalls in the Diagnosis of Peroxisomal Disorders.
Klouwer FC; Huffnagel IC; Ferdinandusse S; Waterham HR; Wanders RJ; Engelen M; Poll-The BT
Neuropediatrics; 2016 Aug; 47(4):205-20. PubMed ID: 27089543
[TBL] [Abstract][Full Text] [Related]
23. [Zellweger syndrome, neonatal adrenoleukodystrophy or infantile Refsum's disease in a case with generalized peroxisome defect?].
Schmitt K; Molzer B; Stöckler S; Tulzer G; Tulzer W
Wien Klin Wochenschr; 1993; 105(11):320-2. PubMed ID: 7687405
[TBL] [Abstract][Full Text] [Related]
24. Peroxisomal disorders.
Aubourg P; Wanders R
Handb Clin Neurol; 2013; 113():1593-609. PubMed ID: 23622381
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological induction of peroxisomes in peroxisome biogenesis disorders.
Wei H; Kemp S; McGuinness MC; Moser AB; Smith KD
Ann Neurol; 2000 Mar; 47(3):286-96. PubMed ID: 10716247
[TBL] [Abstract][Full Text] [Related]
26. Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls.
Moser AB; Kreiter N; Bezman L; Lu S; Raymond GV; Naidu S; Moser HW
Ann Neurol; 1999 Jan; 45(1):100-10. PubMed ID: 9894883
[TBL] [Abstract][Full Text] [Related]
27. Plasma polyenoic very-long-chain fatty acids in peroxisomal disease: biochemical discrimination of Zellweger's syndrome from other phenotypes.
Poulos A; Sharp P; Johnson D
Neurology; 1989 Jan; 39(1):44-7. PubMed ID: 2462697
[TBL] [Abstract][Full Text] [Related]
28. Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions, and pathogenesis.
Powers JM; Moser HW
Brain Pathol; 1998 Jan; 8(1):101-20. PubMed ID: 9458170
[TBL] [Abstract][Full Text] [Related]
29. Clinical approach to inherited peroxisomal disorders: a series of 27 patients.
Baumgartner MR; Poll-The BT; Verhoeven NM; Jakobs C; Espeel M; Roels F; Rabier D; Levade T; Rolland MO; Martinez M; Wanders RJ; Saudubray JM
Ann Neurol; 1998 Nov; 44(5):720-30. PubMed ID: 9818927
[TBL] [Abstract][Full Text] [Related]
30. Peroxisomal disorders I: biochemistry and genetics of peroxisome biogenesis disorders.
Wanders RJ; Waterham HR
Clin Genet; 2005 Feb; 67(2):107-33. PubMed ID: 15679822
[TBL] [Abstract][Full Text] [Related]
31. The peroxisome and the eye.
Folz SJ; Trobe JD
Surv Ophthalmol; 1991; 35(5):353-68. PubMed ID: 1710072
[TBL] [Abstract][Full Text] [Related]
32. Human PEX1 cloned by functional complementation on a CHO cell mutant is responsible for peroxisome-deficient Zellweger syndrome of complementation group I.
Tamura S; Okumoto K; Toyama R; Shimozawa N; Tsukamoto T; Suzuki Y; Osumi T; Kondo N; Fujiki Y
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4350-5. PubMed ID: 9539740
[TBL] [Abstract][Full Text] [Related]
33. [Molecular analysis of peroxisomal disorders].
Shimozawa N
No To Hattatsu; 1998 Mar; 30(2):128-33. PubMed ID: 9545777
[TBL] [Abstract][Full Text] [Related]
34. Biochemical abnormalities in rhizomelic chondrodysplasia punctata.
Hoefler G; Hoefler S; Watkins PA; Chen WW; Moser A; Baldwin V; McGillivary B; Charrow J; Friedman JM; Rutledge L
J Pediatr; 1988 May; 112(5):726-33. PubMed ID: 2452243
[TBL] [Abstract][Full Text] [Related]
35. Nonsense and temperature-sensitive mutations in PEX13 are the cause of complementation group H of peroxisome biogenesis disorders.
Shimozawa N; Suzuki Y; Zhang Z; Imamura A; Toyama R; Mukai S; Fujiki Y; Tsukamoto T; Osumi T; Orii T; Wanders RJ; Kondo N
Hum Mol Genet; 1999 Jun; 8(6):1077-83. PubMed ID: 10332040
[TBL] [Abstract][Full Text] [Related]
36. Complementation analysis in patients with the clinical phenotype of a generalised peroxisomal disorder.
Steinberg SJ; Fensom AH
J Med Genet; 1996 Apr; 33(4):295-9. PubMed ID: 8730284
[TBL] [Abstract][Full Text] [Related]
37. Late onset white matter disease in peroxisome biogenesis disorder.
Barth PG; Gootjes J; Bode H; Vreken P; Majoie CB; Wanders RJ
Neurology; 2001 Dec; 57(11):1949-55. PubMed ID: 11769739
[TBL] [Abstract][Full Text] [Related]
38. History of the cerebrohepatorenal syndrome of Zellweger and other peroxisomal disorders.
Zellweger H; Maertens P; Superneau D; Wertelecki W
South Med J; 1988 Mar; 81(3):357-64. PubMed ID: 2450404
[TBL] [Abstract][Full Text] [Related]
39. Genetic relation between the Zellweger syndrome, infantile Refsum's disease, and rhizomelic chondrodysplasia punctata.
Wanders RJ; Saelman D; Heymans HS; Schutgens RB; Westerveld A; Poll-Thé BT; Saudubray JM; Van den Bosch H; Strijland A; Schram AW
N Engl J Med; 1986 Mar; 314(12):787-8. PubMed ID: 2419755
[No Abstract] [Full Text] [Related]
40. Transformation and characterization of mutant human fibroblasts defective in peroxisome assembly.
Okamoto H; Suzuki Y; Shimozawa N; Yajima S; Masuno M; Orii T
Exp Cell Res; 1992 Aug; 201(2):307-12. PubMed ID: 1639130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
